glp-1 agonist review receptor agonists show promise in treating substance use disorders Frontiers | Exploring the multifaceted

Ozempic Face After GLP-1 Weight Loss: How Fat Transfer Restores Natural Facial Volume GLP-1 medications have transformed the way people lose weight but for some, fast fat loss can also lead to unexpected changes in the face

Eli Lilly and Novo Nordisk are closing in on deals with the Trump administration that would exchange deep discounts on their weight loss drugs for coverage under Medicare, per Endpoints News

The clinical results so far are hard to ignore

GLP-1 Receptor Agonists and the Eye: Evidence, Mechanisms, and Clinical Guidance A new multidisciplinary expert consensus published in Diabetes, Obesity & Metabolism (2025) brings clarity to a question often raised in clinical practice: Do GLP-1 receptor agonists increase the risk of ocular complications such as diabetic retinopathy or optic neuropathy

Management with fluids, electrolytes, and insulin led to rapid recovery